- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.12. | BIBBINSTRUMENTS AB: BiBBInstruments receives additional orders for EndoDrill GI from the U.S. | 1 | Cision News | ||
| BIBBINSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 03.12. | BIBBINSTRUMENTS AB: U.S. Tour Fall 2025 - BiBB Strengthens Its Presence in the American Market | 1 | Cision News | ||
| 09.09. | BIBBINSTRUMENTS AB: Initial Results from Mayo Clinic Indicate Potential of EndoDrill GI in Tissue Culture-Based Pancreatic Cancer Research | 2 | Cision News | ||
| 04.09. | BIBBINSTRUMENTS AB: BiBB Engages EUS Pioneer Professor Peter Vilmann as Scientific Advisor | 1 | Cision News | ||
| 11.08. | BIBBINSTRUMENTS AB: Henry Ford St. John Hospital Reports First U.S. Liver Biopsy Cases with EndoDrill GI | 1 | Cision News |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| SOTERA HEALTH | 17,700 | 0,00 % | Sotera Health Company: Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results | Q2 2025 net revenues increased 6.4% to $294 million, or 6.0% on a constant currency basis(1), compared to Q2 2024Q2 2025 net income of $8 million or $0.03 per diluted share, compared to net income... ► Artikel lesen | |
| SURGERY PARTNERS | 15,870 | +1,54 % | Mizuho Securities Reaffirm Bullish Stance on Surgery Partners (SGRY) | ||
| INSPIRE MEDICAL SYSTEMS | 95,45 | -0,35 % | Bleichmar Fonti & Auld: Inspire Medical Systems, Inc. (INSP) Investors are Notified that Company has been Sued for Securities Fraud after 32% Stock Drop and are Urged to Contact BFA Law | New York, New York--(Newsfile Corp. - December 26, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 31,880 | -1,24 % | Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| TANDEM DIABETES | 22,350 | -0,58 % | Tandem Diabetes upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 | ||
| LANTHEUS | 66,70 | +0,03 % | Lantheus Holdings, Inc.: Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update | Recorded third quarter 2025 worldwide revenue of $384.0 million, GAAP fully diluted earnings per share of $0.41, adjusted fully diluted earnings per share of $1.27 and free cash flow of $94.7 millionSeparately... ► Artikel lesen | |
| HEARTFLOW | 29,830 | -2,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ATRICURE | 40,330 | -0,54 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.09.2025 | The following instruments on XETRA do have their first trading 18.09.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.09.2025
Aktien
1 US64119N6085 Netskope Inc.
2 IE00BFY8C754... ► Artikel lesen | |
| GENEDX | 134,29 | -1,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen |
Das Unternehmen BIBBINSTRUMENTS AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,003 (-1,16 %) liegt der Kurs bei 0,255 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIBBINSTRUMENTS AB finden Sie auf Wallstreet Online.